🇮🇱 Lumoxiti in Israel

Lumoxiti (MOXETUMOMAB PASUDOTOX) regulatory status in Israel.

Marketing authorisation

MOH

  • Status: likely_approved

Lumoxiti in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in Israel

Frequently asked questions

Is Lumoxiti approved in Israel?

Yes. MOH has authorised it.

Who is the marketing authorisation holder for Lumoxiti in Israel?

AstraZeneca is the originator. The local marketing authorisation holder may differ — check the official source linked above.